Syncona careers
WebSyncona is a leading healthcare company focused on investing in and building global leaders in life science. Their vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders. They seek to partner with the best, brightest and most ambitious minds in science WebCareers at Syncona. [email protected]; Investor enquiries. 020 3981 7909; [email protected]; Related content. About us. Investors. Sign-up for …
Syncona careers
Did you know?
WebEd is a Partner of Syncona Partners LLP. Previously, he was Chief Executive Officer of Biotica Technology Ltd. Prior to joining Biotica in 2007, Ed spent 12 years in the US, … WebJun 17, 2024 · Syncona Ltd, (“Syncona”), a leading healthcare company focused on founding, building and funding a portfolio of global leaders in life science, today announces its Final Results for the year ended 31 March 2024. Financial performance
WebOct 1, 2024 · Syncona, is a leading FTSE 250 healthcare company focused on creating, building and scaling a portfolio of global leaders in life science. Our vision is to build a … WebJohn Bradshaw is the Chief Financial Officer of Syncona Investment Management Ltd. He has worked extensively with companies in the life science sector as a part-time and interim CFO. He was previously CFO of Gyrus Group PLC and qualified as a chartered accountant with Arthur Andersen. John has a degree in Law from the University of Liverpool.
WebApr 13, 2024 · As of last trade, Syncona Limited (SYNC:LSE) traded at 151.53, 11.41% above the 52 week low of 136.01 set on Mar 20, 2024. Data delayed at least 20 minutes, as of Apr 11 2024 09:01 BST. WebMar 5, 2024 · Syncona Partners LLP uses 14 technology products and services including HTML5 , Google Analytics , and Google Fonts, according to G2 Stack. Syncona Partners LLP is actively using 31 technologies for its website, according to BuiltWith. These include Viewport Meta , IPhone / Mobile Compatible , and SPF.
WebSyncona Ltd (Syncona) is a closed-ended investment company. Its services include founding, building, and funding companies. The company makes investments in life sciences companies including gene therapy, cell therapy, biologics, and small molecule fields. Syncona’s portfolio companies include Freeline Therapeutics, SwanBio …
WebJul 23, 2015 · Syncona can take the long view when necessary, able to concentrate investment into opportunities as technology is validated. www.synconapartners.com About positron emission tomography (PET) Positron emission tomography (PET) is a test that uses a special type of camera and a tracer (radioactive chemical) to examine biochemical … former mayors of vancouverWebChris is the Chief Investment Officer of Syncona Investment Management Ltd. He is currently Chairman at five Syncona companies: NightStar Therapeutics (NASDAQ:NITE), Freeline Therapeutics, Gyroscope Therapeutics, Swan Therapeutics and Orbit Biomedical. He has been instrumental in their foundation and development including the acquisition of … former mcdonald\\u0027s ceo cabinetWebCAREERS - AviadoBio. We use strictly necessary cookies to make our website work, as well as other cookies (including those of third-party providers) to evaluate website usage and serve fonts. You have the option to accept use of all cookies on this website or manage your cookie settings using the toggles below. Please see our Cookie Policy for ... former mcdonald\\u0027s ceoWebSyncona, is a leading FTSE 250 healthcare company focused on founding, building and funding a portfolio of global leaders in life science. Our vision is to build a sustainable, diverse portfolio ... former mayors of washington dcWebEd Hodgkin provides his perspectives from a career in early-stage biotech. Life Science industry; Syncona; 28.06.21. Encouraging diversity in ... is registered in England no. … former mayor turned talk show host jerryWebSyncona is a leading healthcare company focused on investing in and building global leaders in life science. Their vision is to deliver transformational treatments to patients in … former mcdonald\\u0027s employeesWebSyncona Partners LLP has made 3 diversity investments. Their most recent diversity investment was on May 18, 2024, when SwanBio Therapeutics raised $56M. Syncona Partners LLP has had 8 exits. Syncona Partners LLP 's most notable exits include Neogene Therapeutics , Autolus , and Freeline. Syncona Partners LLP has acquired AGTC on Oct … different sources of water in uttarakhand